Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
Portfolio Pulse from Benzinga Insights
Eli Lilly and Co (NYSE:LLY) has seen a significant bearish stance from big-money investors, as revealed by options trading data. The sentiment is predominantly bearish with 87% against 12% bullish. Large trades have targeted a price range of $750.0 to $830.0 for LLY over the last 3 months. The trading volume and open interest trends in options indicate a keen interest in these price levels. Eli Lilly, a major drug firm, is approaching its earnings announcement with its stock price slightly up and potentially nearing overbought territory.
April 09, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly has seen a bearish sentiment from large investors, with options trading indicating a target price range of $750-$830. The company is nearing its earnings announcement, and the stock is slightly up but may be approaching overbought territory.
The bearish sentiment from large investors, as indicated by the options trading data, suggests a potential downside risk for LLY's stock price in the short term. The upcoming earnings announcement adds to the uncertainty, potentially impacting the stock's performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100